Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis

Surfactant Dysfunction and Lung Inflammation in the Female Mouse Model of Lymphangioleiomyomatosis

(2015) Elena N. Atochina-Vasserman et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

(2015) Tea Pemovska et al.   NATURE

NOS2 Is Critical to the Development of Emphysema in Sftpd Deficient Mice but Does Not Affect Surfactant Homeostasis

(2014) Lars Knudsen et al.   PLoS One

Folliculin Controls Lung Alveolar Enlargement and Epithelial Cell Survival through E-Cadherin, LKB1, and AMPK

(2014) Elena A. Goncharova et al.   Cell Reports

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors

(2013) Manuela Schmidinger   EJC SUPPLEMENTS

Lymphatic Endothelial Differentiation in Pulmonary Lymphangioleiomyomatosis Cells

(2013) Jennifer M. Davis et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients

(2013) Philip S. Hall et al.   JACC-Heart Failure

Lymphangioleiomyomatosis

(2012) Francis X. McCormack et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium

(2012) Tara Karnezis et al.   CANCER CELL

Lymphangioleiomyomatosis — a wolf in sheep’s clothing

(2012) Elizabeth P. Henske et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors

(2012) M. McTigue et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prevention of Alveolar Destruction and Airspace Enlargement in a Mouse Model of Pulmonary Lymphangioleiomyomatosis (LAM)

(2012) E. A. Goncharova et al.   Science Translational Medicine

Early Alveolar Epithelial Dysfunction Promotes Lung Inflammation in a Mouse Model of Hermansky-Pudlak Syndrome

(2011) Elena N. Atochina-Vasserman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells

(2011) E. A. Goncharova et al.   MOLECULAR AND CELLULAR BIOLOGY

Serum Vascular Endothelial Growth Factor-D Prospectively Distinguishes Lymphangioleiomyomatosis From Other Diseases

(2010) Lisa R. Young et al.   CHEST

Mitochondria protection of baicalein against oxidative damage via induction of manganese superoxide dismutase

(2010) In Kyung Lee et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis

(2010) S. R. Johnson et al.   EUROPEAN RESPIRATORY JOURNAL

Vascular Endothelial Growth Factors C and D Induces Proliferation of Lymphangioleiomyomatosis Cells through Autocrine Crosstalk with Endothelium

(2009) Rachel B. Issaka et al.   AMERICAN JOURNAL OF PATHOLOGY

Viral aggregating and opsonizing activity in collectin trimers

(2009) Kevan L. Hartshorn et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Serum Vascular Endothelial Growth Factor-D Levels in Patients With Lymphangioleiomyomatosis Reflect Lymphatic Involvement

(2009) Connie G. Glasgow et al.   CHEST

Immune Reconstitution during Pneumocystis Lung Infection: Disruption of Surfactant Component Expression and Function by S-Nitrosylation

(2009) E. N. Atochina-Vasserman et al.   JOURNAL OF IMMUNOLOGY

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

(2008) D. D. Hu-Lowe et al.   CLINICAL CANCER RESEARCH